Radioterapia śródoperacyjna w raku sutka

Jones C, Lancaster R. Evolution of Operative Technique for Mastectomy. Surg Clin North Am. 2018 Aug;98(4):835-844. doi: 10.1016/j.suc.2018.04.003. Epub 2018 May 21. PMID: 30005777.

Tao, Z., Shi, A., Lu, C. et al. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys 72, 333–338 (2015). https://doi.org/10.1007/s12013-014-0459-6

Noszczyk, Wysocki et. al.. Chirurgia Repetytorium, Wydawnictwo Lekarskie PZWL, wydanie II uaktualnione, Warszawa 2020 ISBN 978-83-200-5385-2

Liu Y, Nguyen N, Colditz GA. Links between alcohol consumption and breast cancer: a look at the evidence. Womens Health (Lond). 2015 Jan;11(1):65-77. doi: 10.2217/whe.14.62. PMID: 25581056; PMCID: PMC4299758.

Filippini SE, Vega A. Breast cancer genes: beyond BRCA1 and BRCA2. Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1358-72. doi: 10.2741/4185. PMID: 23747889.

Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger HL, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, Sütterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Le Blanc-Onfroy M, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McCready D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph DJ, Tobias JS. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836. PMID: 32816842; PMCID: PMC7500441.

Sun MS, Liu HJ, Liu YH, Xu L, Ye JM. Intraoperative radiotherapy versus whole-breast external beam radiotherapy, and other factors associated with the prognosis of early breast cancer treated with breast-conserving surgery and radiotherapy: a retrospective study from SEER database. Transl Cancer Res. 2020 Nov;9(11):7125-7139. doi: 10.21037/tcr-20-2441. PMID: 35117317; PMCID: PMC8798017.

Danny R. Youlden, Susanna M. Cramb, Nathan A.M. Dunn, Jennifer M. Muller, Christopher M. Pyke, Peter D. Baade, The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality, Cancer Epidemiology, Volume 36, Issue 3, 2012, Pages 237-248, ISSN 1877-7821, https://doi.org/10.1016/j.canep.2012.02.007.

Coughlin, S.S. (2019). Epidemiology of Breast Cancer in Women. In: Ahmad, A. (eds) Breast Cancer Metastasis and Drug Resistance. Advances in Experimental Medicine and Biology, vol 1152. Springer, Cham. https://doi.org/10.1007/978-3-030-20301-6_2

Pilar A, Gupta M, Ghosh Laskar S, Laskar S. Intraoperative radiotherapy: review of techniques and results. Ecancermedicalscience. 2017 Jun 29;11:750. doi: 10.3332/ecancer.2017.750. PMID: 28717396; PMCID: PMC5493441.

Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, Elias AD, Baskin-Bey ES, Cardoso F. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2019 Jan;173(1):37-48. doi: 10.1007/s10549-018-4921-9. Epub 2018 Sep 28. PMID: 30267249; PMCID: PMC7513797.

Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW. Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On. Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):455-62. doi: 10.1158/1055-9965.EPI-15-0803. Epub 2015 Dec 8. PMID: 26646362

Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017 Nov 1;13(11):1387-1397. doi: 10.7150/ijbs.21635. PMID: 29209143; PMCID: PMC5715522.

Zohre Momenimovahed & Hamid Salehiniya (2019) Epidemiological characteristics of and risk factors for breast cancer in the world, Breast Cancer: Targets and Therapy, 11:, 151-164, DOI: 10.2147/BCTT.S176070

Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B, Burdan F. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017 Dec 23;24(4):549-553. doi: 10.26444/aaem/75943. Epub 2017 Jul 18. PMID: 29284222.

Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer Epidemiol. 2017 Jun;48:140-146. doi: 10.1016/j.canep.2017.04.010. Epub 2017 May 23. PMID: 28549339; PMCID: PMC5482318.

Apantaku LM. Breast cancer diagnosis and screening. Am Fam Physician. 2000 Aug 1;62(3):596-602, 605-6. PMID: 10950215

Dr. Robert A. Smith PhD, Dr. Debbie Saslow PhD, Kimberly Andrews Sawyer, Dr. Wylie Burke MD, PhD, Dr. Mary E. Costanza MD, Dr. W. Phil Evans III MD, Dr. Roger S. Foster Jr. MD, Dr. Edward Hendrick PhD, Dr. Harmon J. Eyre MD, Ms., Dr. Steven Sener MD, merican Cancer Society Guidelines for Breast Cancer Screening: Update 2003, A Cancer Journal for Clinicians, volume 53, Issue 3, 2003 American Cancer Society, https://doi.org/10.3322/canjclin.53.3.141

Seyed Hamed Jafari, Zahra Saadatpour, Arash Salmaninejad, Fatemeh Momeni, Mojgan Mokhtari, Javid Sadri Nahand, Majid Rahmati, Hamed Mirzaei, Mojtaba Kianmehr, Breast cancer diagnosis: Imaging techniques and biochemical markers, Journal of Cellular Physiology, Volume 233, Issue 7, July 2018, https://doi.org/10.1002/jcp.26379

Anand K. Narayan MD, PhD, Christoph I. Lee MD, MS and Constance D. Lehman MD, PhD, Screening for Breast Cancer, Medical Clinics of North America, 2020-11-01, Volume 104, Issue 6, Pages 1007-1021, Copyright © 2020 Elsevier Inc.

Løberg M, Lousdal ML, Bretthauer M, Kalager M. Benefits and harms of mammography screening. Breast Cancer Res. 2015 May 1;17(1):63. doi: 10.1186/s13058-015-0525-z. PMID: 25928287; PMCID: PMC4415291.

Jaime Geisel, Madhavi Raghu, Regina Hooley, The Role of Ultrasound in Breast Cancer Screening: The Case for and Against Ultrasound, Seminars in Ultrasound, CT and MRI, Volume 39, Issue 1, 2018, Pages 25-34, ISSN 0887-2171, https://doi.org/10.1053/j.sult.2017.09.006.

Liu, Y., Wang, Y., Feng, S. et al. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer. Breast Cancer Res Treat 197, 515–523 (2023). https://doi.org/10.1007/s10549-022-06817-8

Guo R, Lu G, Qin B, Fei B. Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review. Ultrasound Med Biol. 2018 Jan;44(1):37-70. doi: 10.1016/j.ultrasmedbio.2017.09.012. Epub 2017 Oct 26. PMID: 29107353; PMCID: PMC6169997.

Ritse M. Mann, Nariya Cho, Linda Moy, Breast MRI: State of the Art, Radiology 2019; 292:520–536, DOI: https://doi.org/10.1148/radiol.2019182947

Seyed Hamed Jafari, Zahra Saadatpour, Arash Salmaninejad, Fatemeh Momeni, Mojgan Mokhtari, Javid Sadri Nahand, Majid Rahmati, Hamed Mirzaei, Mojtaba Kianmehr, Breast cancer diagnosis: Imaging techniques and biochemical markers, Journal of Cellular Physiology, Volume 233, Issue 7, Pages 5200-5213, July 2018

Nida Iqbal, Naveed Iqbal, Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications, Hindawi Publishing Corporation, Molecular Biology International, Volume 2014, Article ID 852748, 9 pages, http://dx.doi.org/10.1155/2014/852748

Michael J. Duffy, Denis Evoy, Enda W. McDermott, CA 15-3: Uses and limitation as a biomarker for breast cancer, Clinica Chimica Acta, Volume 411, Issues 23–24, 2010, Pages 1869-1874, ISSN 0009-8981, https://doi.org/10.1016/j.cca.2010.08.039.

Duffy MJ, McGowan PM, Harbeck N, Thomssen C, Schmitt M. uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res. 2014 Aug 22;16(4):428. doi: 10.1186/s13058-014-0428-4. PMID: 25677449; PMCID: PMC4423643.

Adel Almogren, Julia Abdullah, Kshipra Ghapure, Kimiko Ferguson, Vladislav V. Glinsky, Kate Rittenhouse-Olson. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy. Front. Biosci. (Schol Ed) 2012, 4(3), 840–863. https://doi.org/10.2741/S304

Prionas ND, Stephens SJ, Blitzblau RC. Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast. Semin Radiat Oncol. 2022 Jul;32(3):245-253. doi: 10.1016/j.semradonc.2022.01.012. PMID: 35688523.

Fisusi FA, Akala EO. Drug Combinations in Breast Cancer Therapy. Pharm Nanotechnol. 2019;7(1):3-23. doi: 10.2174/2211738507666190122111224. PMID: 30666921; PMCID: PMC6691849.

Drăgănescu M, Carmocan C. Hormone Therapy in Breast Cancer. Chirurgia (Bucur). 2017 Jul-Aug;112(4):413-417. doi: 10.21614/chirurgia.112.4.413. PMID: 28862117.

Solmaz Hashemi, Seyedmohammadreza Javadi, Mohammad Esmaeil Akbari, Hamidreza Mirzaei, Seied Rabi Mahdavi “Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer” Int J Surg Oncol. 2021; 2021: 2476527. Published online 2021 Apr 16. doi: 10.1155/2021/2476527

Kaiser J, Reitsamer R, Kopp P, Gaisberger C, Kopp M, Fischer T, Zehentmayr F, Sedlmayer F, Fastner G. Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer. Breast Care (Basel). 2018 Jul;13(3):162-167. doi: 10.1159/000489637. Epub 2018 May 30. PMID: 30069175; PMCID: PMC6062668.

Roberto Orecchia, Umberto Veronesi, Intraoperative electrons, Seminars in Radiation Oncology, Volume 15, Issue 2, 2005, Pages 76-83, ISSN 1053-4296, https://doi.org/10.1016/j.semradonc.2004.10.009.

U Veronesi, R Orecchia, A Luini, G Gatti, M Intra, S Zurrida, G Ivaldi, G Tosi, M Ciocca, A Tosoni, F De Lucia, A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated, European Journal of Cancer, Volume 37, Issue 17, 2001, Pages 2178-2183, ISSN 0959-8049, https://doi.org/10.1016/S0959-8049(01)00285-4

Razieh Rashidfar, Sareh Karbasi, Maziyar Mahdavi, Mohammad Amin Mosleh-Shirazi, Dosimetric characteristics of the LIAC intraoperative radiotherapy beams: Assessment of sensitivity to measurement errors at the commissioning phase, Radiation Physics and Chemistry, Volume 205, 2023, 110737, ISSN 0969-806X, https://doi.org/10.1016/j.radphyschem.2022.110737.

Laplana, M., García-Marqueta, M., Sánchez-Fernández, J.J. et al. Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM®) for accelerated partial breast irradiation (APBI). Clin Transl Oncol 24, 1732–1743 (2022). https://doi.org/10.1007/s12094-022-02823-w

Watson, P.G.F., Bekerat, H., Papaconstadopoulos, P., Davis, S. and Seuntjens, J. (2018), An investigation into the INTRABEAM miniature x-ray source dosimetry using ionization chamber and radiochromic film measurements. Med. Phys., 45: 4274-4286. https://doi.org/10.1002/mp.13059

Jacobson Geraldine M., Siochi Ramon Alfredo, Low-Energy Intraoperative Radiation Therapy and Competing Risks of Local Control and Normal Tissue Toxicity ,Frontiers in Oncology, Volume 7, 2017

Qi Liu, PhD, Frank Schneider, PhD, Lin Ma, MSc, Frederik Wenz, MD, and Carsten Herskind, PhD Relative Biologic Effectiveness (RBE) of 50 kV X-rays Measured in a Phantom for Intraoperative Tumor-Bed Irradiation International Journal of Radiation Oncology, Biology, Physics, Volume 85, Issue 4

Shayna L. Showalter MD, Gina Petroni PhD, Daniel M. Trifiletti MD, Bruce Libby PhD, Anneke T. Schroen MD, MPH, David R. Brenin MD, Parchayi Dalal BA, Mark Smolkin MS, Kelli A. Reardon MD and Timothy N. Showalter MD, MPH, A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial, International Journal of Radiation Oncology, Biology, Physics, 2016-09-01, Volume 96, Issue 1, Pages 46-54, Copyright © 2016 Elsevier Inc

Furhang, E.E., Sillanpaa, J.K., Hu, K.S., Harrison, L.B. (2011). HDR-IORT: Physics and Techniques. In: Gunderson, L., Willett, C., Calvo, F., Harrison, L. (eds) Intraoperative Irradiation. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-61779-015-7_4

Ryan Jones, Bruce Libby, Shayna L. Showalter, David R. Brenin, David D. Wilson, Anneke Schroen, Monica Morris, Kelli A. Reardon, John Morrison and Timothy N. Showalter, Dosimetric comparison of192 Ir high-dose-rate brachytherapy vs. 50 kV x-rays as techniques for breast intraoperative radiation therapy: Conceptual development of image-guided intraoperative brachytherapy using a multilumen balloon applicator and in-room CT imaging, Brachytherapy, 2014-09-01, Volume 13, Issue 5, Pages 502-507, Copyright © 2014 American Brachytherapy Society

Lei, J., Wang, Y., Bi, Z. et al. Intraoperative radiotherapy (IORT) versus whole-breast external beam radiotherapy (EBRT) in early stage breast cancer: results from SEER database. Jpn J Radiol 38, 85–92 (2020). https://doi.org/10.1007/s11604-019-00891-7

Meneveau MO, Petroni GR, Varhegyi NE, Hulse JC, Schroen AT, Brenin DR, Janowski EM, Berger AC, Lazar MA, Simone NL, Showalter TN, Showalter SL. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT. Brachytherapy. 2020 Sep-Oct;19(5):679-684. doi: 10.1016/j.brachy.2020.05.002. Epub 2020 Jun 20. PMID: 32571746; PMCID: PMC7494626.

Sperk, E., Welzel, G., Keller, A. et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat 135, 253–260 (2012). https://doi.org/10.1007/s10549-012-2168-4

Leatherman J, Nicholas C, Cusick T, Cooke E, Ablah E, Okut H, Hunt D. Intra-operative Radiation Therapy versus Whole Breast External Beam Radiotherapy: A Comparison of Patient-Reported Outcomes. Kans J Med. 2021 Jul 9;14:170-175. doi: 10.17161/kjm.vol1415147. PMID: 34262637; PMCID: PMC8274810.

Kraus-Tiefenbacher U, Bauer L, Scheda A, Schoeber C, Schaefer J, Steil V, Wenz F. Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy. BMC Cancer. 2007 Sep 14;7:178. doi: 10.1186/1471-2407-7-178. PMID: 17854511; PMCID: PMC2039741